Literature DB >> 16308504

Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis.

Takahiro Ohara1, Yuji Hashimoto, Akihiko Matsumura, Makoto Suzuki, Mitsuaki Isobe.   

Abstract

BACKGROUND: Progression of aortic stenosis (AS) influences the prognosis in chronic dialysis (CD) patients, but there have been few studies in Japanese patient populations. METHODS AND
RESULTS: The progression of AS was examined in 16 CD patients (68+/-10 years) and 82 non-dialysis patients (73+/-11 years). The mean follow-up was 32 and 40 months, respectively. The calcium-phosphate product was increased in CD patients (49+/-14 mg/dl vs 30+/-5 mg/dl; p<0.0001). At entry, the peak transaortic gradient detected by Doppler echocardiography was lower in CD patients (42+/-12 mmHg vs 57+/-22 mmHg; p<0.05). At follow-up, there was no difference between the 2 groups in that value (69+/-31 mmHg vs 71+/-27 mmHg). Decreasing rate of calculated aortic valvular area was increased in CD patients (0.14+/-0.13 cm2/year vs 0.06+/-0.09 cm2/year; p<0.05) and the calcification of the aortic valve was more severe at follow up in CD patients. The mortality was higher in CD patients (75 vs 28%; p<0.001).
CONCLUSIONS: AS appeared to progress rapidly in CD patients and therefore early aortic valve replacement may be necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308504     DOI: 10.1253/circj.69.1535

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  18 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Outcomes of Transcatheter and Surgical Aortic Valve Replacement in Patients on Maintenance Dialysis.

Authors:  Fahad Alqahtani; Sami Aljohani; Khaled Boobes; Elad Maor; Assem Sherieh; Charanjit S Rihal; David R Holmes; Mohamad Alkhouli
Journal:  Am J Med       Date:  2017-06-14       Impact factor: 4.965

3.  Higher visit-to-visit intra-dialytic blood pressure is associated with the progression of aortic valve stenosis in chronic hemodialysis patients.

Authors:  Naoki Norioka; Shinichi Iwata; Shiro Yanagi; Hideshi Ishii; Kenichi Sugioka; Kimio Kamimori; Takahiro Ota; Marco R Di Tullio; Shunichi Homma; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2015-10-05       Impact factor: 2.037

Review 4.  Mechanisms and treatment of extraosseous calcification in chronic kidney disease.

Authors:  Markus Ketteler; Hansjörg Rothe; Thilo Krüger; Patrick H Biggar; Georg Schlieper
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 5.  Echocardiographic assessment of cardiac structure and function in chronic renal disease.

Authors:  Kaoru Dohi
Journal:  J Echocardiogr       Date:  2019-07-08

6.  [Renal insufficiency and cardiovascular diseases].

Authors:  S Kücükköylü; L C Rump
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

Review 7.  Selection of artificial valve for the patients on hemodialysis.

Authors:  Hirofumi Takemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-07

8.  Aortic valve area: meta-analysis of diagnostic performance of multi-detector computed tomography for aortic valve area measurements as compared to transthoracic echocardiography.

Authors:  Rajnil G Shah; Gian M Novaro; Rodolfo J Blandon; Mitchell S Whiteman; Craig R Asher; Jacobo Kirsch
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-07       Impact factor: 2.357

9.  Proteinuria is an independent predictor of rapid progression of mild to moderate aortic stenosis in patients with preserved renal function.

Authors:  You-Jung Choi; Jun-Bean Park; In-Chang Hwang; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim; Dae-Won Sohn
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-20       Impact factor: 2.357

10.  ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.

Authors:  Mikko A Simolin; Tanja X Pedersen; Susanne Bro; Mikko I Mäyränpää; Satu Helske; Lars B Nielsen; Petri T Kovanen
Journal:  BMC Cardiovasc Disord       Date:  2009-03-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.